{"id":"https://openalex.org/W2000226437","doi":"https://doi.org/10.1055/s-2007-979501","title":"Changes in Platelet Markers of Obsessive-Compulsive Patients During a Double-Blind Trial of Fluvoxamine versus Clomipramine","display_name":"Changes in Platelet Markers of Obsessive-Compulsive Patients During a Double-Blind Trial of Fluvoxamine versus Clomipramine","publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W2000226437","doi":"https://doi.org/10.1055/s-2007-979501","mag":"2000226437","pmid":"https://pubmed.ncbi.nlm.nih.gov/9442546"},"language":"en","primary_location":{"id":"doi:10.1055/s-2007-979501","doi":"https://doi.org/10.1055/s-2007-979501","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2007-979501","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012010863","display_name":"Donatella Marazziti","orcid":"https://orcid.org/0000-0002-4021-5829","observed_orcids":["https://orcid.org/0000-0002-4021-5829"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Donatella Marazziti","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026077616","display_name":"Chiara Pfanner","orcid":"https://orcid.org/0000-0002-6970-3578","observed_orcids":["https://orcid.org/0000-0002-6970-3578"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]},{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Pfanner","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Pisa, Italy","Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","institution_ids":["https://openalex.org/I4210091493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003834887","display_name":"Lionella Palego","orcid":"https://orcid.org/0000-0003-3881-0220","observed_orcids":["https://orcid.org/0000-0003-3881-0220"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lionella Palego","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Pisa, Italy","University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009627550","display_name":"Anita Gemignani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Gemignani","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Pisa, Italy","University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034129507","display_name":"Alessandro Milanfranchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Milanfranchi","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Pisa, Italy","University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090817981","display_name":"Susanna Ravagli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Susanna Ravagli","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Pisa, Italy","University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065008740","display_name":"Patrizia Lensi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Patrizia Lensi","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Pisa, Italy","University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065840333","display_name":"Silvio Presta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Presta","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Pisa, Italy","University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110198324","display_name":"G.B. Cassano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Cassano","raw_affiliation_strings":["Institute of Psychiatry, University of Pisa, Pisa, Italy","University of Pisa,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"University of Pisa,#TAB#","institution_ids":["https://openalex.org/I108290504"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.2089,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.93073134,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"30","issue":"06","first_page":"245","last_page":"249"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":1.0},{"id":"https://openalex.org/keywords/platelet-serotonin-transporter","display_name":"platelet serotonin transporter","score":0.8230000138282776},{"id":"https://openalex.org/keywords/5-ht-transporter","display_name":"5-HT transporter","score":0.7039999961853027},{"id":"https://openalex.org/keywords/phenol-sulfotransferase","display_name":"phenol sulfotransferase","score":0.7960000038146973},{"id":"https://openalex.org/keywords/translocator-protein-tspo","display_name":"translocator protein (TSPO)","score":0.9290000200271606},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.8939999938011169},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":1.0},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibitors","display_name":"serotonin reuptake inhibitors","score":0.890999972820282},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.9718552827835083},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.939565896987915},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.5137413740158081},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4913605749607086},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4422116279602051},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34645190834999084},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.33681148290634155},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.2647309899330139},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.15349140763282776},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015239","descriptor_name":"Arylsulfotransferase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050486","descriptor_name":"Serotonin Plasma Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-2007-979501","doi":"https://doi.org/10.1055/s-2007-979501","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2007-979501","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},{"id":"pmid:9442546","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9442546","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324499","display_name":"Universit\u00e0 di Pisa","ror":"https://ror.org/03ad39j10"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2023109621","https://openalex.org/W2001175953","https://openalex.org/W2094409067","https://openalex.org/W2064806958","https://openalex.org/W2022698786","https://openalex.org/W2092790880","https://openalex.org/W2408920763","https://openalex.org/W2094730148","https://openalex.org/W2013466617","https://openalex.org/W2015140013"],"abstract_inverted_index":{"Abnormalities":[0],"of":[1,44,59,68,99,127,158,173,206,237],"platelet":[2,27],"serotonin":[3,216],"(5-HT)":[4],"transporter,":[5,84],"which":[6,80,91,131,165],"are":[7,32],"supposed":[8],"to":[9,73,203,211,215,233],"reflect":[10],"similar":[11],"dysfunctions":[12],"in":[13,22,30,41,96,146,168,194,198],"the":[14,42,57,66,69,82,121,135,171,183,192,204,207,228,238],"central":[15],"nervous":[16],"system":[17],"(CNS),":[18],"have":[19],"been":[20],"reported":[21],"obsessive-compulsive":[23,103],"disorder":[24,104],"(OCD).":[25],"Other":[26],"parameters":[28],"altered":[29],"OCD":[31,199],"represented":[33],"by":[34],"phenolsulfotransferase":[35],"(PST)":[36],"activity,":[37,86],"an":[38,139],"enzyme":[39],"involved":[40],"catabolism":[43],"catecholic":[45],"neuro-transmitters,":[46],"and":[47,75,87,107,143,209,219],"peripheral":[48,93],"benzodiazepine":[49,94],"receptors.":[50],"Since":[51],"no":[52,144,186],"information":[53],"is":[54],"available":[55],"on":[56],"behavior":[58],"these":[60],"putative":[61],"markers":[62],"during":[63],"antiobsessive":[64],"treatments,":[65],"aim":[67],"present":[70],"study":[71],"was":[72,166],"measure":[74],"compare":[76],"3H-imipramine":[77],"(3H-IMI)":[78],"binding,":[79,90,149],"labels":[81,92],"5-HT":[83],"PST":[85,141,184,229],"3H-PK":[88,147],"11,195":[89,148],"receptors,":[95],"a":[97,109,124,212,224,235],"group":[98],"18":[100],"patients":[101,122],"with":[102,111,134,152,160],"(OCD)":[105],"before":[106],"after":[108],"treatment":[110,159],"fluvoxamine":[112],"versus":[113],"clomipramine.":[114],"The":[115],"results":[116],"showed":[117,185],"that":[118,191],"at":[119],"baseline":[120],"had":[123],"decreased":[125],"number":[126,172],"3H-IMI":[128,174,195],"binding":[129,175,196],"sites,":[130],"correlated":[132],"negatively":[133],"Y-BOCS":[136],"total":[137],"score,":[138],"increased":[140,177],"activity":[142,230],"difference":[145],"as":[150,223],"compared":[151],"healthy":[153],"volunteers.":[154],"After":[155],"eight":[156],"weeks":[157],"either":[161],"clomipramine":[162],"or":[163],"fluvoxamine,":[164],"effective":[167],"all":[169],"patients,":[170],"sites":[176,197],"significantly":[178],"toward":[179],"normal":[180],"values,":[181],"while":[182],"change.":[187],"These":[188],"findings":[189],"suggest":[190],"reduction":[193],"may":[200],"be":[201,221,234],"related":[202],"severity":[205],"illness":[208],"possibly":[210],"positive":[213],"response":[214],"re-uptake":[217],"inhibitors,":[218],"might":[220],"considered":[222],"state-dependent":[225],"marker,":[226],"whereas":[227],"would":[231],"seem":[232],"trait":[236],"illness.":[239]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}